Home
Conditions
Estrogen Receptor Positive

Clinical trial condition

Estrogen Receptor Positive

Explore clinical trials studying Estrogen Receptor Positive. Study availability and eligibility vary by location and protocol.

29 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Estrogen Receptor Positive trial results

Completed

Exercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer Survivors

NCT03523195

Conditions: Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, +18 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery

NCT02219789

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor Positive, +9 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

MK2206 in Combination With Anastrozole, Fulvestrant, or Anastrozole and Fulvestrant in Treating Postmenopausal Women With Metastatic Breast Cancer

NCT01344031

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor Positive, +7 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer

NCT01928186

Conditions: Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +14 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen

NCT00118157

Conditions: Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +11 more
Locations: Harper University Hospital - DMC Detroit, Michigan, United States

Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

NCT01522820

Conditions: Adenocarcinoma, Adnexal Diseases, Anaplastic Astrocytoma, +137 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors

NCT01281150

Conditions: Adult Solid Neoplasm, Breast Diseases, Breast Neoplasms, +16 more
Locations: Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States

UPMC-Magee Womens Hospital Pittsburgh, Pennsylvania, United States

University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy

NCT04692103

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor Positive, +6 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Active, Not Recruiting

Radiation Therapy Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Breast Cancer

NCT03359954

Conditions: Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma, +1 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Estrogen Receptor Positive

Estrogen Receptor Positive trial results

Related conditions